000 03586nam a22004815i 4500
001 978-94-007-5842-1
003 DE-He213
005 20140220082939.0
007 cr nn 008mamaa
008 130217s2013 ne | s |||| 0|eng d
020 _a9789400758421
_9978-94-007-5842-1
024 7 _a10.1007/978-94-007-5842-1
_2doi
050 4 _aRC261-271
072 7 _aMJCL
_2bicssc
072 7 _aMED062000
_2bisacsh
082 0 4 _a614.5999
_223
100 1 _aPfeffer, Ulrich.
_eeditor.
245 1 0 _aCancer Genomics
_h[electronic resource] :
_bMolecular Classification, Prognosis and Response Prediction /
_cedited by Ulrich Pfeffer.
264 1 _aDordrecht :
_bSpringer Netherlands :
_bImprint: Springer,
_c2013.
300 _aVI, 588 p. 65 illus., 61 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aPreface -- Genomic Pathology of Lung Cancer -- Understanding Melanoma Progression by Gene Expression Signatures -- Prognostic testing in uveal melanoma -- Capturing and Deciphering the Molecular Signatures of Head and Neck Cancer -- Predictive and Prognostic Biomarkers for Colorectal Cancer -- Expression Profiling of Hepatocellular Carcinoma -- Kidney Cancer Genomics: Paving the Road to a New Paradigm of Personalized Medicine -- 8 Pancreatic cancer genomics -- Breast Cancer Genomics: From Portraits to Landscapes -- Genomic landscape of ovarian cancer -- Genetics of Endometrial Carcinoma -- Usefulness of molecular biology in follicular-derived thyroid tumors - From translationnal research to clinical practice -- Sarcomas Genetics: From point mutation to complex karyotype, from diagnosis to therapies -- Novel molecular acquisitions in leukemias -- Where do we stand in the genomics of lymphomas?- The Genomics of Multiple Myeloma and Its Relevance in the Molecular Classification and Risk Stratification of the Disease -- Index.
520 _aThe combination of molecular biology, engineering and bioinformatics has revolutionized our understanding of cancer revealing a tight correlation of the molecular characteristics of the primary tumor in terms of gene expression, structural alterations of the genome, epigenetics and mutations with  its propensity to metastasize and to respond to therapy. It is not just one or a few genes, it is the complex alteration of the genome that determines cancer development and progression. Future management of cancer patients will therefore rely on thorough molecular analyses of each single case. Through this book, students, researchers and oncologists will obtain a comprehensive picture of what the first  ten years of cancer genomics have revealed. Experts in the field describe, cancer by cancer, the progress made and its implications for diagnosis, prognosis and treatment of cancer. The deep impact on the clinics and the challenge for future translational research become evident. 
650 0 _aMedicine.
650 0 _aOncology.
650 0 _aGene expression.
650 0 _aDNA microarrays.
650 1 4 _aBiomedicine.
650 2 4 _aCancer Research.
650 2 4 _aGene Expression.
650 2 4 _aMicroarrays.
650 2 4 _aMolecular Medicine.
650 2 4 _aBiomedicine general.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9789400758414
856 4 0 _uhttp://dx.doi.org/10.1007/978-94-007-5842-1
912 _aZDB-2-SBL
999 _c99732
_d99732